Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease final results from the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial

2014

Circulation (Baltimore) , Volume 130 - Issue 14 p. 1146- 1157

Additional Metadata
Keywords	Coronary artery bypass, Cost-benefit analysis, Drug-eluting stents, Percutaneous coronary intervention, Randomized, controlled trials as topic
Persistent URL	doi.org/10.1161/CIRCULATIONAHA.114.009985, hdl.handle.net/1765/83410
Journal	Circulation (Baltimore)
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Cohen, D. J., Osnabrugge, R., Magnuson, E., Wang, K., Li, H., Chinnakondepalli, K., … Serruys, P. (2014). Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease final results from the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial. Circulation (Baltimore), 130(14), 1146–1157. doi:10.1161/CIRCULATIONAHA.114.009985

Publication